Immunomodulating Nanomedicine for Cancer Therapy

被引:128
作者
Liu, Zhigang [1 ,2 ]
Jiang, Wen [2 ]
Nam, Jutaek [3 ,4 ]
Moon, James J. [3 ,4 ,5 ]
Kim, Betty Y. S. [6 ,7 ,8 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, Dept Radiotherapy,Affiliated Canc Hosp,Xiangya Sc, Changsha 410013, Hunan, Peoples R China
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
[3] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[6] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA
[7] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA
[8] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
基金
中国国家自然科学基金;
关键词
Nanomedicine; cancer immunotherapy; cancer vaccine; drug delivery; nanotechnology; ANTIGEN-PRESENTING CELLS; RNA DELIVERY; T-CELLS; NANOPARTICLES; EXPANSION; AGONISTS; DESIGN; DEATH;
D O I
10.1021/acs.nanolett.8b02340
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.
引用
收藏
页码:6655 / 6659
页数:5
相关论文
共 38 条
[1]   Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer [J].
Bear, Adham S. ;
Kennedy, Laura C. ;
Young, Joseph K. ;
Perna, Serena K. ;
Almeida, Joao Paulo Mattos ;
Lin, Adam Y. ;
Eckels, Phillip C. ;
Drezek, Rebekah A. ;
Foster, Aaron E. .
PLOS ONE, 2013, 8 (07)
[2]   Principles of nanoparticle design for overcoming biological barriers to drug delivery [J].
Blanco, Elvin ;
Shen, Haifa ;
Ferrari, Mauro .
NATURE BIOTECHNOLOGY, 2015, 33 (09) :941-951
[3]   Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy [J].
Chen, Qian ;
Xu, Ligeng ;
Liang, Chao ;
Wang, Chao ;
Peng, Rui ;
Liu, Zhuang .
NATURE COMMUNICATIONS, 2016, 7
[4]   Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells [J].
Cheung, Alexander S. ;
Zhang, David K. Y. ;
Koshy, Sandeep T. ;
Mooney, David J. .
NATURE BIOTECHNOLOGY, 2018, 36 (02) :160-+
[5]   Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy [J].
Chiang, Chih-Sheng ;
Lin, Yu-Jung ;
Lee, Rachel ;
Lai, Yen-Ho ;
Cheng, Hung-Wei ;
Hsieh, Chia-Hung ;
Shyu, Woei-Cherng ;
Chen, San-Yuan .
NATURE NANOTECHNOLOGY, 2018, 13 (08) :746-+
[6]   Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells (vol 6, pg 1522, 2006) [J].
Dumortier, Helene ;
Lacotte, Stephanie ;
Pastorin, Giorgia ;
Marega, Riccardo ;
Wu, Wei ;
Bonifazi, Davide ;
Briand, Jean-Paul ;
Prato, Maurizio ;
Muller, Sylviane ;
Bianco, Alberto .
NANO LETTERS, 2006, 6 (12) :3003-3003
[7]   Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy [J].
Fan, Yuchen ;
Kuai, Rui ;
Xup, Yao ;
Ochyl, Lukasz J. ;
Irvine, Darrell J. ;
Moon, James J. .
NANO LETTERS, 2017, 17 (12) :7387-7393
[8]   Immunogenic cell death in cancer and infectious disease [J].
Galluzzi, Lorenzo ;
Buque, Aitziber ;
Kepp, Oliver ;
Zitvogel, Laurence ;
Kroemer, Guido .
NATURE REVIEWS IMMUNOLOGY, 2017, 17 (02) :97-111
[9]   Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles [J].
Gao, Weiwei ;
Fang, Ronnie H. ;
Thamphiwatana, Soracha ;
Luk, Brian T. ;
Li, Jieming ;
Angsantikul, Pavimol ;
Zhang, Qiangzhe ;
Hu, Che-Ming J. ;
Zhang, Liangfang .
NANO LETTERS, 2015, 15 (02) :1403-1409
[10]   Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect [J].
Hammink, Roel ;
Mandal, Subhra ;
Eggermont, Loek J. ;
Nooteboom, Marco ;
Willems, Peter H. G. M. ;
Tel, Jurjen ;
Rowan, Alan E. ;
Figdor, Carl G. ;
Blank, Kerstin G. .
ACS OMEGA, 2017, 2 (03) :937-945